Last update: February 19th 2014
November 18th 2013

EU Regulation on clinical trials: An urgent...

At the ENVI Committee’s vote on the Clinical Trials Regulation on 29 May 2013, Members of the European Parliament (MEPs) took a clear stance in support of enhanced data transparency.

Read More

September 27th 2013

TRANSPARENCY IN THE PUBLIC INTEREST: How the...

The European Medicines Agency (EMA) draft policy on “publication and access to clinical-trial data” could pave the way to a new era in the disclosure of clinical data on medicines.

Read More

June 20th 2013

Declaration of Helsinki, draft text for public...

14 June 2013 - Comments from The Nordic Cochrane Centre and the International Society of Drug Bulletins 

April 23th 2013

Choose Transparency: A message to the Members...

The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society representatives we would like to draw your attention not only to the dangers it encompasses but also to the opportunities it brings along.

for members only

NEWSLETTER

2013

April 22th 2013

April

Download NewsLetter ISDB (650 KB)


ISDB Publications

Manuals & booklets

October 01th 2008

ISDB Booklet

ISDB Information Booklet
Independence from drug companies is a key element of our policy

booklet october 2008 english (639 KB) - spanish (624 KB)

ISDB - International Society of Drug bullettins

Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it

© 2014